The largest database of trusted experimental protocols

Scid beige cb17 cg prkdcscidlystbg 1 crl

Manufactured by Charles River Laboratories

The SCID/beige (CB17.Cg-PrkdcscidLystbg-1/Crl) is a laboratory mouse model characterized by severe combined immunodeficiency (SCID) and a beige coat color mutation. This model is widely used in research fields such as immunology, cancer, and infectious disease studies.

Automatically generated - may contain errors

2 protocols using scid beige cb17 cg prkdcscidlystbg 1 crl

1

Patient-Derived Xenograft Tumor Models with Adipose Stem Cell Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PDX models used in this study WHIM20 (isolated from a patient who developed the Y537S mutation) and WHIM43 (D538G mutation) were obtained from Washington University in St. Louis (Horizons Discovery Group, Waterbeach UK). All animal procedures were reviewed and approved by Tulane University IACUC. SCID/beige (CB17.Cg-PrkdcscidLystbg-1/Crl) 4–6-week-old female mice were obtained from Charles River Laboratory. Intact tumor pieces were removed and sliced with a scalpel to 3mm x 3mm and coated with 100 uL phenol-free growth factor reduced Matrigel (BD Biosciences). Control groups had PDX tumor coated in Matrigel and implanted bilaterally in the mammary fat pads under isoflurane and oxygen. In ASC groups, 106 pooled donors (n = 6) of lnASCs or obASCs were resuspended in Matrigel and coated the tumor. Where indicated, estradiol pellets were implanted subcutaneously in the lateral area of the neck (0.72 mg, 60-day release; Innovative Research of America). Tumors were implanted into the fifth mammary fat pad bilaterally under isoflurane and oxygen anesthesia delivered by nose cone and animals were given 5mg/kg/day meloxicam for three days post-surgery. Tumors were measured by digital caliper every three to four days. At endpoint (tumors reach 750–1000 mm3) blood and lungs were collected for analysis. PDX derived cells were cloned out from PDX tumors.
+ Open protocol
+ Expand
2

PDX Model of Breast Cancer with ASCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PDX model used in this study, TU-BcX-2 K1, was derived from the biopsy specimen of an African-American patient that had node negative invasive ductal carcinoma at the time of biopsy. Tumor tissue was obtained through the Louisiana Cancer Research Consortium (LCRC) Biospecimen Core in compliance with NIH regulations and institutional guidelines and approved by the Institutional Review Board at Tulane University and LCRC. All animal procedures were reviewed and approved by Tulane University IACUC. SCID/beige (CB17.Cg-PrkdcscidLystbg-1/Crl) 4–6-week-old female mice were obtained from Charles River Laboratory. Intact tumor pieces were removed and sliced with a scalpel to 3 mm × 3 mm and coated with 100 μL phenol-free growth factor reduced Matrigel (BD Biosciences). In indicated groups, 106 pooled donors (n = 6) of lnASCs or obASCs were resuspended in Matrigel and coated the tumor. Tumors were implanted into the mammary fat pads bilaterally under isoflurane and oxygen anesthesia delivered by mask and animals were given 5 mg/kg/day meloxicam for 3 days post-surgery. Tumors were measured by digital caliper every three to 4 days. At endpoint (tumors reach 750–1000 mm3), blood, lungs, and tumor were collected for analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!